Frameworks for Digital Advertising
Standards in Medicine.

Italy · Advertising framework

Radio spots and spoken promotions for digital health products in Italy

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Medical-device claims must match the assessed purpose

Legal requirement — paraphrased

Applies when: The advertised product or software function is a medical device under the MDR.

For a regulated medical device, Article 7 prohibits misleading text, names and images, including unsupported functions, a false impression of treatment or diagnosis, omission of likely risks, and uses outside the purpose assessed for conformity. This includes software when it meets the medical-device definition.

Sources: EU Medical Devices Regulation 2017/745

Device advertising has an Italian authorisation layer

Regulator guidance

Applies when: The advertised offer is a device or IVD; software follows this route only if classified accordingly.

Check the national rules for DM and IVD public advertising, the product’s intended user and the applicable ministerial exemptions. Where authorisation is required, approval relates to the message and media. EU conformity alone does not replace this national advertising review.

Sources: Licenze di pubblicità sanitaria; 2025 guidelines for advertising DM, IVD and PMC

Channel rules

Check the complete consumer-facing message

Regulator guidance

The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.

Sources: EU Unfair Commercial Practices Directive 2005/29/EC

Review the audio without visual support

Editorial recommendation

Check product eligibility and applicable radio requirements. Listen at normal speed to the whole spot, including warnings and sponsorship language. A website address does not automatically replace spoken mandatory information.

Campaign workflow

Digital Health Products: prepare the review

Editorial recommendation

Classify each software function separately: lifestyle, medical software or delivery of care. Link accuracy and clinical outcome claims to the advertised software version and population. Review tracking and marketing data flows separately from permission to provide care.

Keep a traceable campaign decision

Editorial recommendation

Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.

Pre-publication checklist

  • Classify each software function separately: lifestyle, medical software or delivery of care.
  • Link accuracy and clinical outcome claims to the advertised software version and population.
  • Review tracking and marketing data flows separately from permission to provide care.
  • Record product or provider eligibility before approving claims.
  • Archive the final creative and its evidence, permissions and review decisions.
  • Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.

Scope and unresolved questions

  • The Gazette text of the 2023 healthcare-promotion amendment and the Ministry OTC/SOP application procedure are documented. A final consolidated-law check, regional provider conditions and exact authorised social-media functions remain necessary. AGCOM disclosure and registration thresholds do not replace healthcare advertising authorisation.
  • This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates

A digital-health offer promoted in radio spots in Italy may combine a lifestyle function, medical software and a clinical service. Identify each advertised function and software version, then review clinical claims and the use of personal data separately.

A radio spot must communicate its meaning without supporting visuals. Listen to the final voiceover at ordinary playback speed and allow enough airtime for the information and any warning applicable to the advertised offer.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: National baseline and category-specific review routes; not an exhaustive compliance opinion

How to use this national baseline

Editorial overview

This framework combines researched national rules with editorial review steps. Italian medicine, device and medical-information baseline plus EU requirements. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.

The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. EU Medical Devices Regulation 2017/745

    European Union · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  2. Licenze di pubblicità sanitaria

    Ministry of Health · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  3. 2025 guidelines for advertising DM, IVD and PMC

    Ministry of Health · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  4. EU Unfair Commercial Practices Directive 2005/29/EC

    European Union · legislation · checked 2026-10-24

    EU framework implemented through national law; sector rules and local implementation also apply.

From framework to action

Local expertise in Italy

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Italy.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

No partners listed in this category yet.

Business & project coordination

No partners listed in this category yet.

Browse partners in Italy

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.